SNCA and Parkinson disease: The well-characterized transgenic rat model we used in this study overexpresses full-length human SNCA and recapitulates typical PD features such as alpha-synuclein aggregation, progressive death of dopaminergic cells with associated motor symptoms, and neuroinflammation [15–17].